Week in Review: Detroit crackdown, NYSE listing bid & LSU proposes big bucks on MMJ
By Bart Schaneman, Omar Sacirbey and John Schroyer Detroit cracks down on dispensaries, a cannabis real estate investment…
News October 21
Latest In: Stocks
Australian MMJ company lists stock, which soars
An Australian developer of marijuana-based medicines that debuted on the Australian Securities Exchange Thursday saw its stock soar…
News October 20GW Pharma scuttles UK listing to trade on U.S. market
GW Pharmaceuticals, a high-flying biotech firm in the United Kingdom that is seeking U.S. regulatory approval for a…
News October 19Cannabis REIT files to be listed on NYSE
A cannabis-focused real estate investment trust has filed to list its shares on the New York Stock Exchange. If approved,…
News October 19Another Canadian MMJ cultivator plans to go public
Canadian medical cannabis producer Emblem is set to go public next month on the TSX Venture Exchange, the…
News October 14
Week in Review: San Diego crackdown, WA eyes organic marijuana & Britain says yes to CBD
By Bart Schaneman and John Schroyer San Diego targets illegal dispensaries while educating consumers about legit operations, Washington…
News October 14Cultivator Aurora Cannabis raises CA$25 million
Alberta, Canada-based medical marijuana cultivator Aurora Cannabis announced Tuesday that it plans to raise 25 million Canadian dollars…
News October 11MassRoots pays off March debt of nearly $1M
MassRoots, the publicly traded cannabis-centric social media site, said Friday it has repaid its creditors after disclosing last…
News October 7
Week in Review: MassRoots’ woes, GW Pharma’s good news & pro-legalization polls
By Omar Sacirbey and John Schroyer MassRoots lands in financial hot water, GW Pharmaceuticals takes a step closer…
News September 30GW Pharma’s latest clinical trial successful, stock soars
British cannabis company GW Pharmaceuticals has conducted a successful clinical trial in which it treated epileptic children with…
News September 27
Latest Sponsored
